Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to ...

with around 70% of patients ultimately developing liver metastases. Treatment options for metastatic disease are scarce, and while surgery remains the gold standard, many patients need additional ...

A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...

A new study led by researchers at the University of Cambridge has revealed the mechanism behind how aspirin could reduce ...

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the ...

The photosensitizer was demonstrated to be effective in the in situ treatment of colorectal cancer through the induction of pyroptosis and immunogenic cell death (ICD), resulting in the inhibition of ...

PFS and OS benefits over chemotherapy were maintained for more than 2 years, and many patients had durable responses to enfortumab vedotin and pembrolizumab.

Among 215 patients with a non-metastatic HCC diagnosis ... from the morphological imaging. Initial treatment plans for the 215 patients included liver resection for 33%, percutaneous ablation ...